Networked Scanners
PRODUCTS
-
At Ideagen, we're committed to empowering seamless collaboration and enhancing your document review process. Through strategic alliances with leading technology providers across the life science industry, we offer integrations that amplify the efficiency and effectiveness of your workflows.
-
There are clearly defined pathways for drug approval, and choosing the right regulatory pathway for your drug development program requires a thorough understanding of sections 505(b)(1) and 505(b)(2) of the Federal Food, Drug, and Cosmetics (FD&C) Act.
-
The dB Control dB-9006 Magnum Opus instrument-grade synthesized signal source tunes from 100 MHz to 27 GHz with best-in-class phase noise performance.
-
The Future of Precision Medicine: Radiopharmaceutical Preparation for Targeted Diagnostics and Treatment
Safer and More Effective Radiopharmaceutical Production With Germfree's Advanced Cleanrooms and Equipment Solutions
Radiopharmaceuticals are drugs that contain radioactive isotopes and are used as diagnostic and therapeutic agents. Due to the hazardous nature of radioisotopes, lead shielded aseptic processing equipment is required for their production and handling. These cleanrooms have specific requirements such as HEPA exhaust and biosecurity features to prevent contamination and protect workers.
Germfree’s expertise in designing facilities and equipment for complex critical environments ensures compliant radiopharmaceutical preparation and production at varying scales. Radiopharmaceuticals play a crucial role in advanced therapies, including nuclear medicine and cancer treatment, and are a rapidly growing sector of the biopharmaceutical industry.
-
Discover how a collaborative approach to medical writing ensures the highest standards of excellence and precision in every document produced.
WHITE PAPERS AND CASE STUDIES
-
Preparing CRAs For Success In Oncology: Targeted Training In An Era Of Advanced Therapeutics
Explore the pivotal role of Clinical Research Associates (CRAs) in oncology clinical trials, emphasizing their critical responsibilities and the importance of specialized CRA training programs.
-
Scalable Production Of High-Purity Nanobodies Using Yeast Expression System
Leverage scalable K. pastoris expression systems to produce high-quality nanobodies for cutting-edge therapeutic, diagnostic, and research applications.
-
Immunogenicity Risk Assessment In Drug Candidate Selection
Identify and address potential anti-drug immune responses early in development to streamline your drug’s path to clinical success—start smart and finish fast.
-
Live Biotherapeutic Products: Unique Quality, Manufacturing, And Nonclinical Considerations For Clinical Trial Entry
Live biotherapeutic products (LBPs) represent an emerging frontier in therapeutic development, harnessing living microorganisms to prevent, treat, or cure disease.
-
Developing Amorphous Solid Dispersions For Poorly Soluble Drugs
Discover how a strategic amorphous solid dispersion approach improved bioavailability and advanced a low-solubility compound toward clinical readiness in just four weeks.
-
How Sharp Packaging's Clinical Packaging Process Is 30% Faster
Discover how digitized workflows and real-time verification are helping streamline clinical trial packaging, reduce complexity, and improve quality in a high-stakes, time-sensitive environment.
-
Navigating The European Market's Regulatory Complexities
Prepare your EU launch strategy with this comprehensive guide detailing what is needed to ensure compliance and efficiency in the EU market.
-
Response To FDA Black Box Warning
The FDA has launched an investigation into the risk of T-cell malignancies following CAR-T cell immunotherapies. Review the key points of this announcement concerning the CGT research community.
-
Double-Sided Polishing Services For Precision Optics Enhances Optics Manufacturing Capability
Precision Glass & Optics, a global leader in optical manufacturing and thin film coatings based on single-sided polishing for nearly 40 years, is pleased to announce new double-sided polishing (DSP) capabilities.
-
Overcoming HCP Co-Elution Issues Using Cell Line Engineering
Product quality assessments revealed that a customer’s therapeutic protein had a range of hydrophobic HCPs. Review a solution that took an alternative approach by utilizing cell line engineering.
-
Process Development For Lyophilized Products
Learn to identify potential product failure points and design robust formulations and processes for lyophilized products backed by solid data.
-
Overcoming The Top 3 Challenges In Setting Up And Managing Clinical Trials
Navigating the intricacies of clinical trials demands adept handling of document management, regulatory compliance, and financial forecasting. Learn key strategies for overcoming these hurdles.
NEWS
-
SignWell Launches NOM-151 Compliant E-Signatures In Mexico12/9/2025
Businesses across Mexico now have a more straightforward, more affordable way to sign documents online legally. SignWell, a leading e-signature platform trusted by over 65,000 businesses globally, is now officially offering NOM-151-compliant electronic signatures, ensuring legal validity under Mexican regulations.
-
Sunset Transportation: Shippers Thrive With 3PLs Combining Tech, Expertise, And High-Touch Service3/20/2025
Sunset Transportation ("Sunset"), a premier third-party logistics (3PL) provider and leader in global supply chain solutions, emphasizes the vital role of technology partnerships, staff expertise, and high-touch service in driving success - the perfect combination to withstanding market ebbs and flows.
-
Stahl Launches Syncros: A New Generation Of Sustainable Crosslinkers For Leather Finishing6/16/2025
Stahl, the global leader in speciality coatings and treatments for flexible substrates, proudly introduces Syncros, a novel generation of hyperfunctional carbodiimide crosslinkers designed to bring high performance and sustainability to leather finishing.
-
Q.ANT Unveils Its Second-Generation Photonic Processor To Power The Next Wave Of AI And HPC11/18/2025
Q.ANT today announced the availability of its next-generation Native Processing Unit: The Q.ANT NPU 2, with enhanced nonlinear processing capabilities to deliver orders-of-magnitude gains in energy efficiency and performance for AI and high-performance workloads.